News

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.
The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...